Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominik Wolf

Showing results (281-290 of 331) with videos related to

Pageof 34
Sort By:
Nature Communications|February 27, 2026
NR2F6 deletion revives CAR-T cell function and induces antigen-agnostic immune memory in solid tumorsDominik Humer, Victoria Klepsch, Dietmar Rieder, et al.
Circulation Research|October 3, 2009
Gene therapy with the angiogenic cytokine secretoneurin induces therapeutic angiogenesis by a nitric oxide-dependent mechanismWilfried Schgoer, Markus Theurl, Johannes Jeschke, et al.
ESMO Open|November 24, 2020
Molecular characteristics of <i>BRCA1/2</i> and <i>PALB2</i> mutations in pancreatic ductal adenocarcinomaAndreas Seeber, Kai Zimmer, Florian Kocher, et al.
Molecular Cancer|June 18, 2022
Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancerIsabel Heidegger, Georgios Fotakis, Anne Offermann, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2014
Treatment of acute myeloid leukemia or myelodysplastic syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions--a retrospective multicenter analysis from the German Cooperative Transplant Study GroupThomas Schroeder, Elena Rachlis, Gesine Bug, et al.
Annals of Hematology|December 23, 2022
Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study groupSteffen Koschmieder, Susanne Isfort, Dominik Wolf, et al.
Transplantation and Cellular Therapy|July 2, 2026
Impact of Disease Biology and Bridging Strategy on Outcomes After CAR-T Cell Therapy in Relapsed/Refractory Multiple MyelomaIrene Strassl, Alexander Nikoloudis, Lina Zoe Ruesing, et al.
ESMO Open|June 25, 2020
Molecular profile of BRCA-mutated biliary tract cancersGilbert Spizzo, Alberto Puccini, Joanne Xiu, et al.
Nature|February 21, 2014
The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cellsMagdalena Paolino, Axel Choidas, Stephanie Wallner, et al.
American Journal of Hematology|August 7, 2023
Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine-A prospective cohort study by the AGMTLisa Pleyer, Marc Vaisband, Manuel Drost, et al.
Pageof 34

Showing results (281-290 of 331) with videos related to

Sort By:
Pageof 34
Nature Communications|February 27, 2026
NR2F6 deletion revives CAR-T cell function and induces antigen-agnostic immune memory in solid tumorsDominik Humer, Victoria Klepsch, Dietmar Rieder, et al.
Circulation Research|October 3, 2009
Gene therapy with the angiogenic cytokine secretoneurin induces therapeutic angiogenesis by a nitric oxide-dependent mechanismWilfried Schgoer, Markus Theurl, Johannes Jeschke, et al.
ESMO Open|November 24, 2020
Molecular characteristics of <i>BRCA1/2</i> and <i>PALB2</i> mutations in pancreatic ductal adenocarcinomaAndreas Seeber, Kai Zimmer, Florian Kocher, et al.
Molecular Cancer|June 18, 2022
Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancerIsabel Heidegger, Georgios Fotakis, Anne Offermann, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2014
Treatment of acute myeloid leukemia or myelodysplastic syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions--a retrospective multicenter analysis from the German Cooperative Transplant Study GroupThomas Schroeder, Elena Rachlis, Gesine Bug, et al.
Annals of Hematology|December 23, 2022
Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study groupSteffen Koschmieder, Susanne Isfort, Dominik Wolf, et al.
Transplantation and Cellular Therapy|July 2, 2026
Impact of Disease Biology and Bridging Strategy on Outcomes After CAR-T Cell Therapy in Relapsed/Refractory Multiple MyelomaIrene Strassl, Alexander Nikoloudis, Lina Zoe Ruesing, et al.
ESMO Open|June 25, 2020
Molecular profile of BRCA-mutated biliary tract cancersGilbert Spizzo, Alberto Puccini, Joanne Xiu, et al.
Nature|February 21, 2014
The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cellsMagdalena Paolino, Axel Choidas, Stephanie Wallner, et al.
American Journal of Hematology|August 7, 2023
Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine-A prospective cohort study by the AGMTLisa Pleyer, Marc Vaisband, Manuel Drost, et al.
Pageof 34